272 related articles for article (PubMed ID: 27683014)
1. Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.
Nguyen AT; Baltos JA; Thomas T; Nguyen TD; Muñoz LL; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
Mol Pharmacol; 2016 Dec; 90(6):703-714. PubMed ID: 27683014
[TBL] [Abstract][Full Text] [Related]
2. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A
Miao Y; Bhattarai A; Nguyen ATN; Christopoulos A; May LT
Sci Rep; 2018 Nov; 8(1):16836. PubMed ID: 30442899
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.
Chandrasekera PC; Wan TC; Gizewski ET; Auchampach JA; Lasley RD
Cell Signal; 2013 Apr; 25(4):736-42. PubMed ID: 23291003
[TBL] [Abstract][Full Text] [Related]
5. Quantification of adenosine A(1) receptor biased agonism: Implications for drug discovery.
Baltos JA; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
Biochem Pharmacol; 2016 Jan; 99():101-12. PubMed ID: 26581123
[TBL] [Abstract][Full Text] [Related]
6. A highly conserved tryptophan residue in the fourth transmembrane domain of the A adenosine receptor is essential for ligand binding but not receptor homodimerization.
Suzuki T; Namba K; Yamagishi R; Kaneko H; Haga T; Nakata H
J Neurochem; 2009 Aug; 110(4):1352-62. PubMed ID: 19558453
[TBL] [Abstract][Full Text] [Related]
7. Novel Irreversible Agonists Acting at the A
Jörg M; Glukhova A; Abdul-Ridha A; Vecchio EA; Nguyen AT; Sexton PM; White PJ; May LT; Christopoulos A; Scammells PJ
J Med Chem; 2016 Dec; 59(24):11182-11194. PubMed ID: 27958734
[TBL] [Abstract][Full Text] [Related]
8. Design and pharmacological profile of a novel covalent partial agonist for the adenosine A
Yang X; Dilweg MA; Osemwengie D; Burggraaff L; van der Es D; Heitman LH; IJzerman AP
Biochem Pharmacol; 2020 Oct; 180():114144. PubMed ID: 32653590
[TBL] [Abstract][Full Text] [Related]
9. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.
Figler H; Olsson RA; Linden J
Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687
[TBL] [Abstract][Full Text] [Related]
10. The role of the second and third extracellular loops of the adenosine A1 receptor in activation and allosteric modulation.
Peeters MC; Wisse LE; Dinaj A; Vroling B; Vriend G; Ijzerman AP
Biochem Pharmacol; 2012 Jul; 84(1):76-87. PubMed ID: 22449615
[TBL] [Abstract][Full Text] [Related]
11. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP
J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101
[TBL] [Abstract][Full Text] [Related]
12. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE
Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition.
Maeda K; Das D; Yin PD; Tsuchiya K; Ogata-Aoki H; Nakata H; Norman RB; Hackney LA; Takaoka Y; Mitsuya H
J Mol Biol; 2008 Sep; 381(4):956-74. PubMed ID: 18590744
[TBL] [Abstract][Full Text] [Related]
14. Design and in Vivo Characterization of A
Tosh DK; Rao H; Bitant A; Salmaso V; Mannes P; Lieberman DI; Vaughan KL; Mattison JA; Rothwell AC; Auchampach JA; Ciancetta A; Liu N; Cui Z; Gao ZG; Reitman ML; Gavrilova O; Jacobson KA
J Med Chem; 2019 Feb; 62(3):1502-1522. PubMed ID: 30605331
[TBL] [Abstract][Full Text] [Related]
15. Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosides.
Palaniappan KK; Gao ZG; Ivanov AA; Greaves R; Adachi H; Besada P; Kim HO; Kim AY; Choe SA; Jeong LS; Jacobson KA
Biochemistry; 2007 Jun; 46(25):7437-48. PubMed ID: 17542617
[TBL] [Abstract][Full Text] [Related]
16. 4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives as novel non-nucleoside agonists for the adenosine A
Cosimelli B; Greco G; Laneri S; Novellino E; Sacchi A; Trincavelli ML; Giacomelli C; Taliani S; Da Settimo F; Martini C
Chem Biol Drug Des; 2016 Nov; 88(5):724-729. PubMed ID: 27282729
[TBL] [Abstract][Full Text] [Related]
17. Plasticity of the ligand binding pocket in the bitter taste receptor T2R7.
Liu K; Jaggupilli A; Premnath D; Chelikani P
Biochim Biophys Acta Biomembr; 2018 May; 1860(5):991-999. PubMed ID: 29355483
[TBL] [Abstract][Full Text] [Related]
18. Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity.
Stewart GD; Valant C; Dowell SJ; Mijaljica D; Devenish RJ; Scammells PJ; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2009 Oct; 331(1):277-86. PubMed ID: 19641164
[TBL] [Abstract][Full Text] [Related]
19. Long range effect of mutations on specific conformational changes in the extracellular loop 2 of angiotensin II type 1 receptor.
Unal H; Jagannathan R; Bhatnagar A; Tirupula K; Desnoyer R; Karnik SS
J Biol Chem; 2013 Jan; 288(1):540-51. PubMed ID: 23139413
[TBL] [Abstract][Full Text] [Related]
20. NanoBiT Complementation to Monitor Agonist-Induced Adenosine A
Soave M; Kellam B; Woolard J; Briddon SJ; Hill SJ
SLAS Discov; 2020 Feb; 25(2):186-194. PubMed ID: 31583945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
